MAPT and Alzheimer disease: However, the role of CX3CL1 in microglial activation, along with its contradictory Janus behavior with respect to Aβ accumulation and Tau phosphorylation, could explain why AD but not SNAP patients showed altered levels of CX3CL1 in the CSF.